The Impact of Vitamin D on Skin Aging
The active metabolites of vitamin D<sub>3</sub> (D<sub>3</sub>) and lumisterol (L<sub>3</sub>) exert a variety of antiaging and photoprotective effects on the skin. These are achieved through immunomodulation and include anti-inflammatory actions, regulation of ke...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/16/9097 |
id |
doaj-3cacd89f304149d29e5c30aa839169f5 |
---|---|
record_format |
Article |
spelling |
doaj-3cacd89f304149d29e5c30aa839169f52021-08-26T13:53:58ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-08-01229097909710.3390/ijms22169097The Impact of Vitamin D on Skin AgingGeorgeta Bocheva0Radomir M. Slominski1Andrzej T. Slominski2Department of Pharmacology and Toxicology, Medical University of Sofia, 1431 Sofia, BulgariaDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USADepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USAThe active metabolites of vitamin D<sub>3</sub> (D<sub>3</sub>) and lumisterol (L<sub>3</sub>) exert a variety of antiaging and photoprotective effects on the skin. These are achieved through immunomodulation and include anti-inflammatory actions, regulation of keratinocytes proliferation, and differentiation programs to build the epidermal barrier necessary for maintaining skin homeostasis. In addition, they induce antioxidative responses, inhibit DNA damage and induce DNA repair mechanisms to attenuate premature skin aging and cancerogenesis. The mechanism of action would involve interaction with multiple nuclear receptors including VDR, AhR, LXR, reverse agonism on RORα and -γ, and nongenomic actions through 1,25D<sub>3</sub>-MARRS receptor and interaction with the nongenomic binding site of the VDR. Therefore, active forms of vitamin D<sub>3</sub> including its canonical (1,25(OH)<sub>2</sub>D<sub>3</sub>) and noncanonical (CYP11A1-intitated) D<sub>3</sub> derivatives as well as L<sub>3</sub> derivatives are promising agents for the prevention, attenuation, or treatment of premature skin aging. They could be administrated orally and/or topically. Other forms of parenteral application of vitamin D<sub>3</sub> precursor should be considered to avoid its predominant metabolism to 25(OH)D<sub>3</sub> that is not recognized by CYP11A1 enzyme. The efficacy of topically applied vitamin D<sub>3</sub> and L<sub>3</sub> derivatives needs further clinical evaluation in future trials.https://www.mdpi.com/1422-0067/22/16/9097skin agingphotoagingskin immune responsesvitamin Dvitamin D metabolitesphotoprotection |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Georgeta Bocheva Radomir M. Slominski Andrzej T. Slominski |
spellingShingle |
Georgeta Bocheva Radomir M. Slominski Andrzej T. Slominski The Impact of Vitamin D on Skin Aging International Journal of Molecular Sciences skin aging photoaging skin immune responses vitamin D vitamin D metabolites photoprotection |
author_facet |
Georgeta Bocheva Radomir M. Slominski Andrzej T. Slominski |
author_sort |
Georgeta Bocheva |
title |
The Impact of Vitamin D on Skin Aging |
title_short |
The Impact of Vitamin D on Skin Aging |
title_full |
The Impact of Vitamin D on Skin Aging |
title_fullStr |
The Impact of Vitamin D on Skin Aging |
title_full_unstemmed |
The Impact of Vitamin D on Skin Aging |
title_sort |
impact of vitamin d on skin aging |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1661-6596 1422-0067 |
publishDate |
2021-08-01 |
description |
The active metabolites of vitamin D<sub>3</sub> (D<sub>3</sub>) and lumisterol (L<sub>3</sub>) exert a variety of antiaging and photoprotective effects on the skin. These are achieved through immunomodulation and include anti-inflammatory actions, regulation of keratinocytes proliferation, and differentiation programs to build the epidermal barrier necessary for maintaining skin homeostasis. In addition, they induce antioxidative responses, inhibit DNA damage and induce DNA repair mechanisms to attenuate premature skin aging and cancerogenesis. The mechanism of action would involve interaction with multiple nuclear receptors including VDR, AhR, LXR, reverse agonism on RORα and -γ, and nongenomic actions through 1,25D<sub>3</sub>-MARRS receptor and interaction with the nongenomic binding site of the VDR. Therefore, active forms of vitamin D<sub>3</sub> including its canonical (1,25(OH)<sub>2</sub>D<sub>3</sub>) and noncanonical (CYP11A1-intitated) D<sub>3</sub> derivatives as well as L<sub>3</sub> derivatives are promising agents for the prevention, attenuation, or treatment of premature skin aging. They could be administrated orally and/or topically. Other forms of parenteral application of vitamin D<sub>3</sub> precursor should be considered to avoid its predominant metabolism to 25(OH)D<sub>3</sub> that is not recognized by CYP11A1 enzyme. The efficacy of topically applied vitamin D<sub>3</sub> and L<sub>3</sub> derivatives needs further clinical evaluation in future trials. |
topic |
skin aging photoaging skin immune responses vitamin D vitamin D metabolites photoprotection |
url |
https://www.mdpi.com/1422-0067/22/16/9097 |
work_keys_str_mv |
AT georgetabocheva theimpactofvitamindonskinaging AT radomirmslominski theimpactofvitamindonskinaging AT andrzejtslominski theimpactofvitamindonskinaging AT georgetabocheva impactofvitamindonskinaging AT radomirmslominski impactofvitamindonskinaging AT andrzejtslominski impactofvitamindonskinaging |
_version_ |
1721192463016656896 |